SB 144

  • Maryland Senate Bill
  • 2022 Regular Session
  • Introduced in Senate Sep 22, 2021
  • Passed Senate Feb 24, 2022
  • Passed House Mar 31, 2022
  • Signed by Governor May 12, 2022

Health - Authorization to Prescribe and Administer Amygdalin - Repeal

Votes


Actions


May 12, 2022

Office of the Governor

Approved by the Governor - Chapter 306

Mar 31, 2022

Senate

Returned Passed

House

Third Reading Passed

Mar 30, 2022

House

Favorable Adopted Second Reading Passed

House

Favorable Report by Health and Government Operations

Mar 18, 2022

House

Hearing 3/23 at 1:30 p.m.

Mar 01, 2022

House

Referred Health and Government Operations

Feb 24, 2022

Senate

Third Reading Passed

Feb 22, 2022

Senate

Second Reading Passed

Senate

Favorable Adopted

Feb 21, 2022

Senate

Favorable Report by Finance

Jan 20, 2022

Senate

Hearing 2/10 at 1:00 p.m.

Jan 12, 2022

Senate

First Reading Finance

Sep 22, 2021

Senate

Pre-filed

Bill Text

Bill Text Versions Format
First - Health - Authorization to Prescribe and Administer Amygdalin - Repeal PDF
Third - Health - Authorization to Prescribe and Administer Amygdalin - Repeal PDF
Chapter - Health - Authorization to Prescribe and Administer Amygdalin - Repeal PDF

Related Documents

Document Format
Fiscal and Policy Note PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Maryland General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.